Q & A: “What Price Do We Put on Our Oceans?”

Erik Solheim participates in the largest beach clean-up in history at Versova Beach Clean-Up in Mumbai, India, in October 2016. Photo courtesy of UNEPBy Manipadma JenaNAIROBI/NEW DELHI, Dec 1 2017 (IPS)“Political resolve is the key for succeeding in our fight against oceans pollution,” Erik Solheim, head of UN Environment, who is leading hands-on the organisation’s global campaign to clean up seas and oceans of plastic litter, agricultural run‑off and chemical dumping, told IPS.“It’s about building capacity for strong environmental governance and bolstering political leadership on these issues,” said Solheim, who previously served as Norway’s Minister of the Environment and International Development.“If action is not taken today, we’re lining ourselves up for the ultimate cost – the destruction of our oceans – down the line."“One of the big changes has been an understanding of the issue (of marine pollution) and a realization that we are facing an extremely serious problem. As a result, we’re starting to see a range of initiatives,” he said.“On the community level, there are people like Afroz Shah and Mumbai’s Versova Beach clean-up team, for example. They’re really doing an amazing job of drawing attention to the problem.“Then we’re seeing the “private sector begin to take serious action,” he said. “For example, Dell is changing its packa...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Biodiversity Climate Change Development & Aid Environment Featured Food & Agriculture Global Green Economy Headlines Health IPS UN: Inside the Glasshouse Natural Resources Population Poverty & SDGs Water & Sanitation marine c Source Type: news

Related Links:

Publication date: Available online 22 February 2020Source: Reproductive BioMedicine OnlineAuthor(s): Andrea BUSNELLI, Amerigo VITAGLIANO, Laura MENSI, Stefano ACERBONI, Alessandro BULFONI, Francesca FILIPPI, Edgardo SOMIGLIANAAbstractSeveral epidemiological studies investigated the effects of cancer therapies on fertility. However, conflicting data have been reported.The present systematic review and meta-analysis aims to determine the chances of childbirth in women survived from different types of cancer.We systematically searched Pubmed, MEDLINE, Embase and Scopus, from database inception to July 17, 2019, for published ...
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research
This study aimed to evaluate fertility in female survivors of childhood DTC by assessing various reproductive characteristics combined with anti-Müllerian hormone (AMH) levels (a marker of ovarian reserve). Methods. Female survivors of childhood DTC, diagnosed at ≤18 years of age between 1970 and 2013 were included. Survivors were excluded when follow-up time was less than 5 years or if they developed other malignancies before or after diagnosis of DTC. Survivors filled out a questionnaire regarding reproductive characteristics (e.g. age at menarche and menopause, pregnancies, pregnancy outcomes, need for assisted ...
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
Conclusions Surufatinib demonstrated promising efficacy with a tolerable and manageable safety profile for patients with locally advanced or metastatic MTC, RAI-refractory DTC, or locally advanced, unresectable recurrences unable to receive RAI. PMID: 32075524 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
ConclusionThe pathway is a safe and effective service model to manage patients with HNC at low risk for dysphagia during RT, avoiding unnecessary SP appointments for the patient and service.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
In this study, a highly sensitive and accurate LC–MS/MS method was firstly established for subsequent measurement of PdG in serum of three different female groups: thyroid cancer patients (TCs), healthy controls (HCs) and pregnant women. The factors affecting the sample preparation, MS/MS method, gradient elution program, selection of chromatographic column and internal standard (IS) have been optimized in this study. Compared with enzyme immunoassay (EIA) method, we used LC–MS/MS to shorten analysis time, increase sensitivity, raise specificity, simplify sample preparation, and reduce costs. As a result, the l...
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
Conclusions: Evidence-based guidelines were created to assist clinicians in the optimal surgical management of thyroid disease.
Source: Annals of Surgery - Category: Surgery Tags: ORIGINAL ARTICLES Source Type: research
Conclusion: Evidence-based guidelines were created to assist clinicians in the optimal surgical management of thyroid disease.
Source: Annals of Surgery - Category: Surgery Tags: FEATURES Source Type: research
Conditions:   Solid Tumor;   Medullary Thyroid Cancer Intervention:   Drug: Selpercatinib Sponsors:   Eli Lilly and Company;   Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
More News: Bangladesh Health | Brain | Cancer | Cancer & Oncology | Cardiology | Chemistry | Economy | Environmental Health | Fish | Government | Heart | Hormones | India Health | International Medicine & Public Health | Jobs | Kenya Health | Liver | Minerals | Neurology | Politics | Reproduction Medicine | Rwanda Health | Sports Medicine | Study | Thyroid | Thyroid Cancer | Urology & Nephrology